McKinley Kate
SEC insider (Form 3/4/5 filer). CIK 0001979211. Chief Business Officer at Rani Therapeutics Holdings, Inc. (RANI). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in SAN JOSE, CA.
Companies McKinley Kate has filed insider reports for
- Rani Therapeutics Holdings, Inc. (RANI): Officer, Chief Business Officer
McKinley Kate
CIK: 0001979211
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rani Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 3, 2026RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
805.5K shares- - Aug 1, 2025RANI
Rani Therapeutics Holdings, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
120K shares- - May 23, 2025RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
325K shares- - Dec 13, 2024RANI
Rani Therapeutics Holdings, Inc.
PurchaseDirect18K shares at avg. $1.67$30K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 805,500 | - | - | Direct |
| Aug 1, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award Employee Stock Option (Right to Buy) | 120,000 | - | - | Direct |
| May 23, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 325,000 | - | - | Direct |
| Dec 13, 2024 | RANI Rani Therapeutics Holdings, Inc. | Purchase | 17,960 | $1.67 | $29,993 | Direct |
1-4 of 4 transactions